Delivery Order SPE2DB22D2211-SPE2DB24FPDD9
Award Date
8/13/24
Potential Completion Date
8/14/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distributor Amerisourcebergen Corporation. The $2,782.36 firm fixed price contract is for the supply of GRALISE ER 600 MG tablets, with a completion date of May 6, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which enables the agency to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $18,570.13 and a completion date of October 2, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a $4,578.64 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GRALISE ER 300 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,627.35 firm fixed-price contract is for the delivery of GRALISE ER 300 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of August 10, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,036.96 delivery order contract is for the supply of GRALISE ER 300 MG TABLET 90S, a prescription medication. The contract is a firm fixed price arrangement with a completion date of November 24, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GRALISE ER 600 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $13,072.71 and is a firm fixed price contract with a completion date of June 23, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a larger...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $2,460.65 for the pharmaceutical product "GRALISE ER 300 MG TABLET 90S". The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has received numerous similar awards from DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,799.72 firm fixed-price delivery order is for the supply of GRALISE ER 600 MG TABLET 90S, a prescription medication product. The contract, which has a period of performance ending on July 30, 2024, does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded numerous contracts by various...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GRALISE ER 300 MG TABLET 90S, a prescription medication. The award has a firm fixed price of $2,914.08 and a completion date of June 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop...
This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of the medication GRALISE ER 600 MG TABLET 90S, with a Ceiling Value of $4,766.95 and a completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and designated as SPE2DX. This IDC provides a...